During the last session, TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s traded shares were 0.34 million, with the beta value of the company hitting 2.46. The 52-week high for the TNFA share is $3.50, that puts it down -872.22 from that peak though still a striking 8.33% gain since the share price plummeted to a 52-week low of $0.33. The company’s market capitalization is $0.99M, and the average intraday trading volume over the past 10 days was 0.2 million shares, and the average trade volume was 522.42K shares over the past three months.
TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information
TNF Pharmaceuticals Inc (TNFA) registered a 0.28% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.28% in intraday trading to $0.36, hitting a weekly high. The stock’s 5-day price performance is -4.51%, and it has moved by -16.22% in 30 days. Based on these gigs, the overall price performance for the year is -84.42%. The short interest in TNF Pharmaceuticals Inc (NASDAQ:TNFA) is 0.78 million shares and it means that shorts have 1.18 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 67.29%.
TNFA Dividends
TNF Pharmaceuticals Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders
TNF Pharmaceuticals Inc insiders own 0.59% of total outstanding shares while institutional holders control 15.10%, with the float percentage being 15.19%.
Also, the Mutual Funds coming in first place with the largest holdings of TNF Pharmaceuticals Inc (TNFA) shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund owns about 13.69 shares. This amounts to just over 0.50 percent of the company’s overall shares, with a $4928.0 market value. The same data shows that the other fund manager holds slightly less at 11.21, or about 0.41% of the stock, which is worth about $4036.0.
